206.03-0.50 (-0.24%)
At close: 4:00PM EST
207.00 +0.77 (0.37%)
After hours: 6:32PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 206.53 |
| Open | 206.21 |
| Bid | 207.00 x 800 |
| Ask | 206.22 x 1200 |
| Day's Range | 204.58 - 206.95 |
| 52 Week Range | 108.85 - 224.24 |
| Volume | 305,521 |
| Avg. Volume | 514,558 |
| Market Cap | 29.857B |
| Beta (5Y Monthly) | 0.28 |
| PE Ratio (TTM) | 44.22 |
| EPS (TTM) | 4.66 |
| Earnings Date | Jan 28, 2021 - Feb 01, 2021 |
| Forward Dividend & Yield | 1.56 (0.76%) |
| Ex-Dividend Date | Nov 10, 2020 |
| 1y Target Est | 189.80 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-8% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
View moreRelated Research
- Zacks
Quest Diagnostics (DGX) Grows on Two New Lab-Service Pacts
Quest Diagnostics (DGX) is moving ahead in terms of its growth strategy, which consists of five elements.
- Zacks
Phibro (PAHC) Hurt by Adverse Pricing in Mineral Nutrition Arm
Lower sales of Phibro's (PAHC) Performance Products arm's copper-based products raise concerns.
- Zacks
Tandem Diabetes' (TNDM) Insulin Pump Approved by Health Canada
Tandem Diabetes' (TNDM) t:slim X2 Insulin Pump with Control-IQ Advanced Hybrid Closed-Loop Technology cleared for use in Canada post the receipt of Health Canada approval.
© 2020 Verizon Media. All rights reserved.
